Surgical management of extra-regional lymph node metastasis in colorectal cancer

References

• Jung KW, Park S, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat. 2011;43(1):1–11.
   PubMedGoogle Scholar
• Dahl O, Horn A, Morild I, et al. Low-dose preoperative radiation postpones recurrences in operable rectal cancer. Results of a randomized multicenter trial in western Norway. Cancer. 1990;66(11):2286–2294.
   PubMed Web of Science ®Google Scholar
• Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med. 1997;336(14):980–987.
   PubMed Web of Science ®Google Scholar
• Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638–646.
   PubMed Web of Science ®Google Scholar
• Enker WE, Thaler HT, Cranor ML, et al. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg. 1995;181(4):335–346.
   PubMed Web of Science ®Google Scholar
• Nagawa H, Muto T, Sunouchi K, et al. Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum. 2001;44(9):1274–1280.
   PubMed Web of Science ®Google Scholar
• Delaney CP, Lavery IC, Brenner A, et al. Preoperative radiotherapy improves survival for patients undergoing total mesorectal excision for stage T3 low rectal cancers. Ann Surg. 2002;236(2):203–207.
   PubMed Web of Science ®Google Scholar
• Pepper MS, Tille J-C, Nisato R, et al. Lymphangiogenesis and tumor metastasis. Cell Tissue Res. 2003;314(1):167–177.
   PubMed Web of Science ®Google Scholar
• Min BS, Kim NK, Sohn SK, et al. Isolated paraaortic lymph-node recurrence after the curative resection of colorectal carcinoma. J Surg Oncol. 2008;97(2):136–140.
   PubMed Web of Science ®Google Scholar
• Choi PW, Kim HC, Kim AY, et al. Extensive lymphadenectomy in colorectal cancer with isolated para-aortic lymph node metastasis below the level of renal vessels. J Surg Oncol. 2010;101(1):66–71.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Mochizuki H, Kato T, et al. Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection. Dis Colon Rectum. 2009;52(4):567–576.
   PubMed Web of Science ®Google Scholar
• Shibata D, Paty PB, Guillem JG, et al. Surgical management of isolated retroperitoneal recurrences of colorectal carcinoma. Dis Colon Rectum. 2002;45(6):795–801.
   PubMed Web of Science ®Google Scholar
• Committee on Classification of Regional Lymph Nodes of Japan Society of Clinical, O. Classification of regional lymph nodes in Japan. Int J Clin Oncol. 2003;8(4):248–275.
   PubMedGoogle Scholar
• Greene FL. The American Joint Committee on Cancer: updating the strategies in cancer staging. Bull Am Coll Surg. 2002;87(7):13–15.
   PubMedGoogle Scholar
• Akiyoshi T, Watanabe T, Miyata S, et al. Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease? Ann Surg. 2012;255(6):1129–1134.
   PubMed Web of Science ®Google Scholar
• Ueno M, Oya M, Azekura K, et al. Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer. Br J Surg. 2005;92(6):756–763.
   PubMed Web of Science ®Google Scholar
• Mori T, Takahashi K, Yasuno M. Radical resection with autonomic nerve preservation and lymph node dissection techniques in lower rectal cancer surgery and its results: the impact of lateral lymph node dissection. Langenbecks Arch Surg. 1998;383(6):409–415.
   PubMed Web of Science ®Google Scholar
• Fujita S, Yamamoto S, Akasu T, et al. Prognostic factors of rectal cancer patients with lateral pelvic lymph node metastasis. Hepatogastroenterology. 2012;59(120):2494–2497.
   PubMed Web of Science ®Google Scholar
• Sugihara K, Kobayashi H, Kato T, et al. Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum. 2006;49(11):1663–1672.
   PubMed Web of Science ®Google Scholar
• Arnaud JP, Nordlinger B, Bosset JF, et al. Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of a phase III study of the European organization for research and treatment of cancer. Br J Surg. 1997;84(3):352–357.
   PubMed Web of Science ®Google Scholar
• Masaki T,MT, Yasutomi M. Clinicopathological characteristics of sigmoid colon and rectal cancers with central node involvement ― multi-institutional questionnaire study. J Jpn Soc Coloproctol. 1997;50:318–330.
   Google Scholar
• Min BS, Kim JS, Kim NK, et al. Extended lymph node dissection for rectal cancer with radiologically diagnosed extramesenteric lymph node metastasis. Ann Surg Oncol. 2009;16(12):3271–3278.
   PubMed Web of Science ®Google Scholar
• Grinnell RS. Lymphatic block with atypical and retrograde lymphatic metastasis and spread in carcinoma of the colon and rectum. Ann Surg. 1966;163(2):272–280.
   PubMed Web of Science ®Google Scholar
• Wu Z-Y, Wan J, Li J-H, et al. Prognostic value of lateral lymph node metastasis for advanced low rectal cancer. World J Gastroenterol. 2007;13(45):6048–6052.
   PubMed Web of Science ®Google Scholar
• Lu H-J, Lin J-K, Chen W-S, et al. The prognostic role of para-aortic lymph nodes in patients with colorectal cancer: is it regional or distant disease? PLoS One. 2015;10(6):e0130345.
   Google Scholar
• Engelen SM, Beets-Tan RGH, Lahaye MJ, et al. Location of involved mesorectal and extramesorectal lymph nodes in patients with primary rectal cancer: preoperative assessment with MR imaging. Eur J Surg Oncol. 2008;34(7):776–781.
   PubMed Web of Science ®Google Scholar
• Arii K, Takifuji K, Yokoyama S, et al. Preoperative evaluation of pelvic lateral lymph node of patients with lower rectal cancer: comparison study of MR imaging and CT in 53 patients. Langenbecks Arch Surg. 2006;391(5):449–454.
   PubMed Web of Science ®Google Scholar
• Koh DM, Hughes M, Husband JE. Cross-sectional imaging of nodal metastases in the abdomen and pelvis. Abdom Imaging. 2006;31(6):632–643.
   PubMed Web of Science ®Google Scholar
• Stumpe KD, Urbinelli M, Steinert HC, et al. Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography. Eur J Nucl Med. 1998;25(7):721–728.
   PubMedGoogle Scholar
• Matsuoka H, Nakamura A, Masaki T, et al. Optimal diagnostic criteria for lateral pelvic lymph node metastasis in rectal carcinoma. Anticancer Res. 2007;27(5b):3529–3533.
   PubMed Web of Science ®Google Scholar
• Ogawa S, Hida JI, Ike H, et al. Selection of lymph node-positive cases based on perirectal and lateral pelvic lymph nodes using magnetic resonance imaging: study of the Japanese society for cancer of the colon and rectum. Ann Surg Oncol. 2016;23(4):1187–1194. doi:10.1245/s10434-015-5021-2
   Web of Science ®Google Scholar
• Kim DJ, Kim JH, Ryu YH, et al. Nodal staging of rectal cancer: high-resolution pelvic MRI versus ¹⁸F-FDGPET/CT. J Comput Assist Tomogr. 2011;35(5):531–534.
   PubMed Web of Science ®Google Scholar
• Lee M-J, Yun MJ, Park M-S, et al. Paraaortic lymph node metastasis in patients with intra-abdominal malignancies: CT vs PET. World J Gastroenterol. 2009;15(35):4434–4438.
   PubMed Web of Science ®Google Scholar
• Georgiou P, Tan E, Gouvas N, et al. Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol. 2009;10(11):1053–1062.
   PubMed Web of Science ®Google Scholar
• Kinugasa T, Akagi Y, Ochi T, et al. Lateral lymph-node dissection for rectal cancer: meta-analysis of all 944 cases undergoing surgery during 1975-2004. Anticancer Res. 2013;33(7):2921–2927.
   PubMed Web of Science ®Google Scholar
• NCCN. Rectal cancer guidelines. Feb 2015.
   Google Scholar
• Kusters M, Marijnen CAM, Van De Velde CJH, et al. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol. 2010;36(5):470–476.
   PubMed Web of Science ®Google Scholar
• Moriya Y, Sugihara K, Akasu T, et al. Importance of extended lymphadenectomy with lateral node dissection for advanced lower rectal cancer. World J Surg. 1997;21(7):728–732.
   PubMed Web of Science ®Google Scholar
• Yano H, Moran BJ, Watanabe T, et al. Lateral pelvic lymph-node dissection: still an option for cure. Lancet Oncol. 2010;11(2):114. author reply 114-5
   PubMed Web of Science ®Google Scholar
• Akasu T, Sugihara K, Moriya Y. Male urinary and sexual functions after mesorectal excision alone or in combination with extended lateral pelvic lymph node dissection for rectal cancer. Ann Surg Oncol. 2009;16(10):2779–2786.
   PubMed Web of Science ®Google Scholar
• Watanabe A, Yoriki R, Nakagawa M, et al. A complete response persisting for twelve months with the use of TS-1 in a patient with paraaortic lymph node metastasis of gastric cancer. Gan To Kagaku Ryoho. 2001;28(12):1913–1916.
   PubMedGoogle Scholar
• Stearns MW Jr., Deddish MR. Five-year results of abdominopelvic lymph node dissection for carcinoma of the rectum. Dis Colon Rectum. 1959;2(2):169–172.
   PubMedGoogle Scholar
• Valentini V, Aristei C, Glimelius B, et al. Multidisciplinary rectal cancer management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiother Oncol. 2009;92(2):148–163.
   PubMed Web of Science ®Google Scholar
• Otowa Y, Yamashita K, Kanemitsu K, et al. Treating patients with advanced rectal cancer and lateral pelvic lymph nodes with preoperative chemoradiotherapy based on pretreatment imaging. Onco Targets Ther. 2015;8:3169–3173.
   PubMed Web of Science ®Google Scholar
• Liang J-T. Technical feasibility of laparoscopic lateral pelvic lymph node dissection for patients with low rectal cancer after concurrent chemoradiation therapy. Ann Surg Oncol. 2011;18(1):153–159.
   PubMed Web of Science ®Google Scholar
• Bowne WB, Lee B, Wong WD, et al. Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases. Dis Colon Rectum. 2005;48(5):897–909.
   PubMed Web of Science ®Google Scholar
• Akiyoshi T, Matsueda K, Hiratsuka M, et al. Indications for lateral pelvic lymph node dissection based on magnetic resonance imaging before and after preoperative chemoradiotherapy in patients with advanced low-rectal cancer. Ann Surg Oncol. 2015;22:614–620.
   PubMed Web of Science ®Google Scholar
• Kim MJ, Kim TH, Kim DY, et al. Can chemoradiation allow for omission of lateral pelvic node dissection for locally advanced rectal cancer? J Surg Oncol. 2015;111(4):459–464.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Tsurita G, Muto T, et al. Extended lymphadenectomy and preoperative radiotherapy for lower rectal cancers. Surgery. 2002;132(1):27–33.
   PubMed Web of Science ®Google Scholar
• Ishibe A, Ota M, Watanabe J, et al. Prediction of lateral pelvic lymph-node metastasis in low rectal cancer by magnetic resonance imaging. World J Surg. 2016;40(4):995–1001. doi:10.1007/s00268-015-3299-7
   PubMed Web of Science ®Google Scholar
• Oh H-K, Kang S-B, Lee S-M, et al. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study. Ann Surg Oncol. 2014;21(7):2280–2287.
   PubMed Web of Science ®Google Scholar
• Shihab OC, Shihab OC, Taylor F, et al. Relevance of magnetic resonance imaging-detected pelvic sidewall lymph node involvement in rectal cancer. Br J Surg. 2011;98(12):1798–1804.
   PubMed Web of Science ®Google Scholar
• Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. N Engl J Med. 2005;352(5):476–487.
   PubMed Web of Science ®Google Scholar
• Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med. 2004;351(4):337–345.
   PubMed Web of Science ®Google Scholar
• Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350(23):2335–2342.
   PubMed Web of Science ®Google Scholar
• Miyazawa T, Ebe K, Koide N, et al. Complete response of isolated para-aortic lymph node recurrence from rectosigmoid cancer treated by chemoradiation therapy with capecitabine/oxaliplatin plus bevacizumab: a case report. Case Rep Oncol. 2012;5(2):216–221.
   PubMedGoogle Scholar
• Yasuda S, Kamata H, Machida T, et al. A case of isolated paraaortic lymph node recurrence from colon cancer successfully treated with chemoradiotherapy. Tokai J Exp Clin Med. 2012;37(2):47–50.
   PubMedGoogle Scholar
• Shimizu H, Taniguchi F, Sonoda H, et al. Two cases of advanced rectal cancer resected successfully after neoadjuvant chemotherapy with FOLFOX regimen. Gan To Kagaku Ryoho. 2009;36(12):2073–2075.
   PubMedGoogle Scholar
• Fujii S, Ota M, Ichikawa Y, et al. Paraaortic lymph node metastasis showed CR to UFT/LV therapy in elderly rectal cancer. Hepatogastroenterology. 2010;57(99–100):472–476.
   PubMed Web of Science ®Google Scholar
• Waseda R, Tatsuzawa Y, Imai T, et al. A case of transverse colon cancer with left supraclavicular lymph node metastasis and paraaortic lymph node metastases responding to TS-1. Gan To Kagaku Ryoho. 2005;32(8):1183–1185.
   PubMedGoogle Scholar
• Takenoue T, Yamada Y, Miyagawa S, et al. Cisplatin-5-fluorouracil therapy with remarkable effect and 5-year survival for paraaortic lymph node metastases of rectal carcinoma in females: a case report. Jpn J Clin Oncol. 1999;29(11):582–586.
   PubMed Web of Science ®Google Scholar
• Liu Y-L, Wang Y-H, Yang Y-M, et al. The role of para-aortic lymphadenectomy in surgical management of patients with stage N+ rectal cancer below the peritoneal reflection. Cell Biochem Biophys. 2012;62(1):41–46.
   PubMed Web of Science ®Google Scholar
• Tsarkov PV, Belov YV, Skipenko OG, et al. En bloc resection of abdominal aorta and paraaortic lymph node metastasis of sigmoid cancer. Tech Coloproctol. 2007;11(4):346–349.
   PubMedGoogle Scholar
• Shingai T, Ohue M, Noura S, et al. A long-term disease-free survival case of advanced rectal cancer with massive metastasis to the lateral pelvic and para-aortic lymph nodes. Gan To Kagaku Ryoho. 2010;37(12):2608–2610.
   PubMedGoogle Scholar
• Nagano I, Yamada I, Niwa M, et al. A case of advanced sigmoid colon cancer with metastases in the liver and the paraaortic lymph nodes successfully treated with 5-FU/l-LV and FOLFOX4 followed by S-1 leading to long-term complete response. Gan To Kagaku Ryoho. 2014;41(1):113–116.
   PubMedGoogle Scholar
• Uk BS, Han YD, Cho M, et al. Oncologic outcomes of colon cancer patients with extraregional lymph node metastasis: comparison of isolated paraaortic lymph node metastasis with resectable liver metastasis. Ann Surg Oncol. 2015. doi:10.1245/s10434-015-5027-9. [Epub ahead of print]
   Google Scholar
• Covey AM, Brown KT, Jarnagin WR, et al. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg. 2008;247(3):451–455.
   PubMed Web of Science ®Google Scholar
• Blazer DG 3rd, Kishi Y, Maru DM, et al. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol. 2008;26(33):5344–5351.
   PubMed Web of Science ®Google Scholar
• Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet. 2008;371(9617):1007–1016.
   PubMed Web of Science ®Google Scholar
• Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2013;14(12):1208–1215.
   PubMed Web of Science ®Google Scholar
• Fenwick JD, Tomé WA, Soisson ET, et al. Tomotherapy and other innovative IMRT delivery systems. Semin Radiat Oncol. 2006;16(4):199–208.
   PubMed Web of Science ®Google Scholar
• Kim M-S, Cho CK, Yang KM, et al. Stereotactic body radiotherapy for isolated paraaortic lymph node recurrence from colorectal cancer. World J Gastroenterol. 2009;15(48):6091–6095.
   PubMed Web of Science ®Google Scholar
• Masaki T, Takayama M, Matsuoka H, et al. Intraoperative radiotherapy for oncological and function-preserving surgery in patients with advanced lower rectal cancer. Langenbecks Arch Surg. 2008;393(2):173–180.
   PubMed Web of Science ®Google Scholar
• Konishi T, Kuroyanagi H, Oya M, et al. Multimedia article. Lateral lymph node dissection with preoperative chemoradiation for locally advanced lower rectal cancer through a laparoscopic approach. Surg Endosc. 2011;25(7):2358–2359.
   PubMed Web of Science ®Google Scholar
• Park J-A, Choi G-S, Park JS, et al. Initial clinical experience with robotic lateral pelvic lymph node dissection for advanced rectal cancer. J Korean Soc Coloproctol. 2012;28(5):265–270.
   PubMedGoogle Scholar
• Bae SU, Saklani AP, Hur H, et al. Robotic and laparoscopic pelvic lymph node dissection for rectal cancer: short-term outcomes of 21 consecutive series. Ann Surg Treat Res. 2014;86(2):76–82.
   PubMed Web of Science ®Google Scholar